How do you qualify cleanroom operators for aseptic gowning, and how often must they be requalified?

1The qualification, step by step.

The APS sets the pace: a scheduled run, then incubation of its units, which FDA says should take no less than 14 days and Annex 1 leaves to a scientifically justified, validated choice.²¹ In the example below, 59 days pass between the first training day and authorisation.

Everyone who enters cleanrooms, cleaners and maintenance and monitoring staff included, needs gowning qualification suited to their function and area; the visual and microbial assessment applies to grade A and B access.¹

2Gowning qualification protocol template.

Each line maps to the requirement it meets. Copy it into your procedure.

2.1Visual gowning checklist.

The assessor ticks each line while watching. PIC/S asks for the visual assessment to be documented against defined acceptance criteria; these are Annex 1’s.⁴¹

3Acceptance criteria from Annex 1 Table 6.

Annex 1 says the contact plate and glove print limits in Table 6 apply to the qualification of personnel gowning. PIC/S adds that results should be judged against alert and action levels “per plate and overall”.¹⁴

Annex 1 does not say which row a gowning qualification uses. Decide from where the person’s gloved hands will go, and write the reason into the protocol. FDA sets no numeric limits for gloves or gowns. It asks for levels based on “the relationship of the sampled location to the operation”, and says samples from ISO 5 areas should normally yield no microbiological contaminants.²

4Example: a completed gowning qualification record.

This record is invented. Operator OP-2291 joins vial filling Line 3, a RABS in a grade B room. The protocol asks for three consecutive passing sessions, uses the grade B row of Table 6 as its action limits, treats any growth on a glove as an alert, and allows three series before full retraining.

5How often operators must be requalified: EU and FDA.

FDA’s qualifier matters: “if adverse conditions occur, additional or more frequent requalification could be indicated.”² A manually intensive line is not the automated case, so justify its interval from monitoring data rather than adopting yearly by default. The EU guidelines for advanced therapy medicinal products also ask for gowning competence in grade A and B to be reassessed at least yearly, and for a successful process simulation before routine aseptic work.⁵ For UK sites, MHRA’s GMP guidance page lists EudraLex Volume 4, which holds Annex 1, among the published GMP guidance.⁶

6Judgement calls the sources settle.

• How many sessions. Annex 1 sets no number; PIC/S asks for enough runs to show consistency.¹⁴ For pharmacy compounding, USP’s answers on 〈797〉 fix three successful evaluations in a row at first, each a separate hand hygiene, garbing and fingertip test, then one at each later evaluation.⁷
• Which interventions the APS covers. Annex 1 asks for an authorised list of qualified interventions and an APS long enough to challenge the operators who perform them. PIC/S adds that for manual operations the APS should qualify the interventions each operator is authorised to perform, and that at annual requalification each operator performs every type they do routinely.¹⁴ FDA asks for media fill participation “consistent with the nature of each operator’s duties during routine production.”²
• Isolator operators. The yearly visual and microbial reassessment is written for grade A and B access. Someone working an isolator from a grade C or D room still needs gowning qualification relevant to that area, and still joins an APS each year.¹ See RABS vs isolator.
• Occasional entrants. Unqualified people enter grade B, or grade A in operation, only exceptionally: under a written procedure, supervised by an authorised person, with the access recorded.¹

7What inspectors check and cite.

In a sterile drug inspection, FDA’s compliance program tells investigators to evaluate the programme for qualifying and requalifying people who work in controlled areas, to watch their aseptic technique, and, “For selected employees, verify the training, testing, qualifying, and re-qualifying were done as specified in procedures.” Its quality-system review takes in personnel monitoring results above alert or action levels and trend data. Its list of points to consider gives the questions to prepare for:⁸

• “Does the program include microbiological testing or qualifying employees before they are allowed to work in these areas?”
• “Who performs the sampling of personnel? Is it self-sampling?”
• “Do employees spray their hands with sanitizer or disinfectant before the sample is taken?”

In December 2025 FDA wrote to a PET drug maker:

“Furthermore, you failed to adequately requalify two of the (b)(4) operators at least annually by conducting a media fill to assess their aseptic processing technique. For example, one of your operators had not been requalified to perform PET drug manufacturing using process simulations (media fills) since April 2021. However, the operator manufactured FDG as recently as June 2025.” 3D Imaging Drug Design and Development LLC, warning letter, 4 December 2025⁹

FDA found the response inadequate because it gave no “retrospective assessment of the potential impact to drug products manufactured from 2021 to present.”⁹ A lapsed qualification is a product question, not only a training one.

“The personnel monitoring for operators working in the ISO 5 area was not sufficient to assure sterility. For example, the locations chosen for personnel monitoring were not scientifically justified, nor was the practice of using (b)(4) plates for one hand and (b)(4) for the other. In addition, there was no written procedure for gowning qualification.” Daewoo Pharmaceutical Co., Ltd., warning letter, 2 July 2025¹⁰

“Continuing assessment for operator gowning qualification uses postproduction batch EM for assessment. Personnel sampling for gowning qualification should occur immediately after gowning and gloving. Using postproduction PM sampling does not show the operator’s ability to gown properly.” IntegraDose Compounding Services LLC, Form FDA 483, 12 August 2026¹¹

The same observation found twelve operators carried over from the firm’s previous facility who “did not perform initial hand hygiene and gowning qualifications at this location”: requalify people at a new site. A Form 483 records an investigator’s observations, not a final agency determination.¹¹

8What changed from 2023 to 2026.

• 25 August 2023. The revised Annex 1 came into operation, apart from point 8.123, which followed in August 2024.¹
• 28 October 2026. PIC/S PI 058-1 came into force, with a technical interpretation PIC/S, the EU and WHO agreed should be the same. Its answers on 7.4, 7.6 and 9.34 are used above. PIC/S says it is not meant to introduce new GMP requirements.⁴
• FDA. Its aseptic processing guidance is still the final version of September 2004, and its sterile drug compliance program dates from 2015. The 2025 and 2026 citations above show how investigators apply them.²⁸

9How it runs in Seal.

In Seal, aseptic operator qualification resolves whether a person may enter a grade, work a line or perform an intervention from their current training, gowning assessments, practical demonstrations, APS participation and personnel monitoring, and from any active restriction. Each gowning attempt keeps its garment system, checklist, sample locations, limits, results and assessor, and initial, periodic, remediation and return-to-work assessments stay distinct. A configured check can apply the decision at the batch step, and a connected access-control system can use it at the door.

Media fill records connect each participant to the interventions they actually performed, so being listed on a protocol is not taken as qualification. A personnel monitoring result at action level can place a scoped restriction, such as no grade A intervention, which overrides otherwise valid evidence until requalification restores access.